Medtronic receives CE Mark for CRT pacemakers
Medtronic announced on Feb. 24 that the company had received CE marks for quadripolar cardiac resynchronization therapy (CRT) pacemakers that allow patients to receive MRIs.
The pacemakers are not yet FDA-approved.
In March, the following Medtronic CRT pacemakers will be available in Europe: the Percepta Quad CRT-P MRI SureScan, the Serena Quad CRT-P MRI SureScan and the Solara Quad CRT-P MRI SureScan.
The pacemakers are used to treat patients with heart failure and allow patients access to diagnostic imaging.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.